
Opthea Limited OPT
Geschäftsbericht 2022
hinzugefügt 29.09.2022
Opthea Limited EBITDA per Share 2011-2026 | OPT
EBITDA per Share Jährlich Opthea Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | -1.19 | -0.49 | -0.429 | -0.685 | -1.22 | -1.31 | -1.54 | -2.01 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.429 | -2.01 | -1.11 |
EBITDA per Share anderer Aktien in der Pharmaeinzelhändler
| Name | EBITDA per Share | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-15.2 | - | 2.43 % | $ 254 M | ||
|
AbCellera Biologics
ABCL
|
-0.67 | $ 3.44 | -4.32 % | $ 1.03 B | ||
|
Acorda Therapeutics
ACOR
|
-188 | - | -24.86 % | $ 820 K | ||
|
I-Mab
IMAB
|
0.08 | - | - | $ 866 M | ||
|
Acer Therapeutics
ACER
|
-1.56 | - | 2.71 % | $ 14 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
6.75 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-0.23 | - | -13.47 % | $ 169 M | ||
|
ADMA Biologics
ADMA
|
0.84 | $ 15.36 | -2.17 % | $ 3.66 B | ||
|
Cellectis S.A.
CLLS
|
-2.92 | $ 3.53 | -3.54 % | $ 116 M | ||
|
AgeX Therapeutics
AGE
|
-9.04 K | - | -10.17 % | $ 12.2 K | ||
|
Apellis Pharmaceuticals
APLS
|
0.45 | $ 20.28 | 0.65 % | $ 2.56 B | ||
|
Aeglea BioTherapeutics
AGLE
|
-6.7 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.36 | - | - | $ 26.5 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.22 | - | -1.52 % | $ 24.7 M | ||
|
Akero Therapeutics
AKRO
|
-4.25 | - | - | $ 3.67 B | ||
|
Midatech Pharma plc
MTP
|
-0.09 | - | -18.52 % | $ 27.3 M | ||
|
Akouos
AKUS
|
-2.45 | - | 0.23 % | $ 488 M | ||
|
Alpine Immune Sciences
ALPN
|
-1.72 | - | - | $ 2.17 B | ||
|
Nymox Pharmaceutical Corporation
NYMX
|
-0.15 | - | -19.68 % | $ 18.4 M | ||
|
AlloVir
ALVR
|
-44.1 | - | 4.14 % | $ 49.1 M | ||
|
Aptorum Group Limited
APM
|
0.34 | $ 0.79 | -1.15 % | $ 4.31 M | ||
|
Autolus Therapeutics plc
AUTL
|
-0.92 | $ 1.51 | 1.35 % | $ 385 M | ||
|
China SXT Pharmaceuticals
SXTC
|
-1.83 | $ 2.01 | -1.36 % | $ 2.86 M | ||
|
Galmed Pharmaceuticals Ltd.
GLMD
|
0.03 | $ 0.67 | 7.08 % | $ 624 K | ||
|
Adverum Biotechnologies
ADVM
|
-6.85 | - | - | $ 86.2 M | ||
|
Ampio Pharmaceuticals
AMPE
|
0.15 | - | -11.43 % | $ 502 K | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.69 | - | - | - | ||
|
Anika Therapeutics
ANIK
|
-5.54 | $ 14.05 | -1.44 % | $ 206 M | ||
|
ANI Pharmaceuticals
ANIP
|
3.54 | $ 74.36 | -1.64 % | $ 1.44 B | ||
|
Applied Therapeutics
APLT
|
-0.77 | - | - | $ 8.42 M | ||
|
Aravive
ARAV
|
-1.92 | - | -13.39 % | $ 1.45 M | ||
|
ARCA biopharma
ABIO
|
-5.25 | - | 1052.0 % | $ 415 M | ||
|
Athersys
ATHX
|
-0.382 | - | 3.77 % | $ 22.4 M | ||
|
AVEO Pharmaceuticals
AVEO
|
-1.52 | - | - | $ 521 M | ||
|
Axsome Therapeutics
AXSM
|
-3.34 | $ 162.43 | 0.6 % | $ 8.08 B | ||
|
BioCryst Pharmaceuticals
BCRX
|
-0.01 | $ 8.49 | -0.18 % | $ 1.75 B | ||
|
BridgeBio Pharma
BBIO
|
-2.7 | $ 65.66 | -0.78 % | $ 12.6 B | ||
|
Acasti Pharma
ACST
|
-1.38 | - | 4.01 % | $ 150 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-2.28 | - | -2.5 % | $ 5.88 M | ||
|
BioDelivery Sciences International
BDSI
|
0.38 | - | -4.8 % | $ 255 M | ||
|
BeiGene, Ltd.
BGNE
|
0.42 | - | 0.49 % | $ 251 B | ||
|
Bellerophon Therapeutics
BLPH
|
-2.34 | - | -74.18 % | $ 955 K | ||
|
Bellicum Pharmaceuticals
BLCM
|
-0.87 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
-1.29 | - | -7.31 % | $ 87 M | ||
|
CureVac N.V.
CVAC
|
-2.22 | - | - | $ 867 M | ||
|
Aeterna Zentaris
AEZS
|
-0.08 | - | 5.93 % | $ 314 M | ||
|
BioLineRx Ltd.
BLRX
|
-0.04 | $ 2.69 | -0.74 % | $ 908 M | ||
|
BioMarin Pharmaceutical
BMRN
|
2.55 | $ 61.3 | 1.21 % | $ 11.8 B | ||
|
Burford Capital Limited
BUR
|
1.11 | $ 7.79 | -5.75 % | $ 1.28 B | ||
|
CymaBay Therapeutics
CBAY
|
-0.95 | - | - | $ 3.45 B |